Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 14 of 14

List	Outcome	Time frame	Description
Primary	28 day survival
Secondary	ICU survival
Secondary	Hospital survival
Secondary	Severity of organ dysfunction in the ICU (SOFA score)
Secondary	Duration of ICU stay
Secondary	Time spent on vasopressors (vasopressor free days)
Secondary	Time spent on mechanical ventilation (ventilator free days)
Secondary	Time spent on renal replacement (renal replacement free days)
Secondary	Efficacy of dopamine to correct hypotension
Secondary	Hemodynamic effects
Secondary	Concomitant use of dobutamine or other inotropic agents
Secondary	Tolerance: arrhythmia (incidence of ventricular tachycardia, ventricular fibrillation and atrial fibrillation), myocardial necrosis, skin necrosis, limb or distal extremity ischemia.
Secondary	Occurrence of secondary infections
Secondary	Impact of target blood pressure on outcome

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00314704/registered